Showing results (1731-1740 of 5,935) with videos related to
Sort By:
Pageof 594
The Prostate|May 26, 2020
Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signalsMin Tang, Shenglin Gao, Lei Zhang, et al.The Prostate|May 26, 2020
RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancerAnna Linder, Karin Larsson, Karin Welén, et al.The Prostate|September 1, 2021
Combined 177 Lu-PSMA-617 PRLT and abiraterone acetate versus 177 Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durabilitySonam Suman, Rahul V Parghane, Amit Joshi, et al.The Prostate|May 12, 2021
Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settingsOliver Sartor, Sreevalsa Appukkuttan, Jeffrey Weiss, et al.The Prostate|August 18, 2022
Prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapyMikolaj J Filon, Amani A Gillette, Bing Yang, et al.The Prostate|August 18, 2022
Are higher pre-diagnosis follicle stimulating hormone levels associated with long-term prostate cancer risk?Kyle Dymanus, Lauren E Howard, Taofik Oyekunle, et al.The Prostate|January 1, 1987
Isolation of a 41 kilodalton cytosol protein from the Dunning rat prostatic adenocarcinoma: characterization as depolymerized actin isomersN Nishi, Y Matuo, S Matsui, et al.The Prostate|January 1, 1987
Dihydrotestosterone does not induce prostate adenocarcinoma in L-W ratsM Pollard, D L Snyder, P H LuckertThe Prostate|January 1, 1987
Evolution of fetal and adult thymidine kinase isoenzymes in rat ventral prostates during developmentP Derré, S Samperez, P JouanThe Prostate|November 7, 2022
Impact of the bladder detrusor muscular ring on lower urinary tract symptoms due to benign prostatic hyperplasia: A quantitative MRI analysisKiran R Nandalur, David Walker, Hong Ye, et al.Pageof 594